http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101536224-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-52 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97 |
filingDate | 2008-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101536224-B1 |
titleOfInvention | A skin whitening composition containing extract of Aspergillus oryzae |
abstract | The present invention relates to a composition for whitening skin, which contains an extract of Aspergillus oryzae as an active ingredient. More specifically, the present invention relates to a skin whitening pharmaceutical composition and a cosmetic composition containing a crude extract, a polar solvent extract or a nonpolar solvent extract as an active ingredient . The extract of the present invention effectively inhibits tyrosinase activity, which is an enzyme essential for the melanin biosynthetic process, and inhibits biosynthesis of melanin in B16 melanoma cells, so that the extract can be effectively used as a whitening pharmaceutical composition and a cosmetic composition.n n n Sorghum, tyrosinase, melanin biosynthesis, whitening |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023113355-A1 |
priorityDate | 2008-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 380.